Risk Factors Identified for Cutaneous Squamous Cell Carcinoma Recurrence Timing

Lymphovascular invasion (LVI) and large-caliber or deep perineural invasion (LCDPNI) are strongly associated with early locoregional metastasis of cutaneous squamous cell carcinoma (cSCC), while poor differentiation remains an important predictor of recurrence risk 2 years after diagnosis, according to results of a study published in the Journal of the American Academy of Dermatology.

Key Recurrence Risk Factors and Timelines

Early Relapse (≤ 4 months): Driven heavily by lymphovascular invasion (SHR = 3.01) and large-caliber/deep perineural invasion (SHR = 2.55). These features necessitate aggressive initial staging (such as sentinel lymph node biopsy). [1]
Intermediate Relapse (4 - 24 months): Tumors with high-risk features like diameters ≥20 mm (SHR, 1.89), invasion beyond subcutaneous fat, and desmoplastic growth independently increase the risk of local recurrence and metastasis. [1, 2]
Late Relapse (> 24 months): Poor tumor differentiation remains an important, sustained predictor of relapse risk even beyond two years post-diagnosis. [1]

Patient-Specific and Location Factors

Anatomical Site: Tumors located on high-exposure and delicate regions like the ears, lips, and scalpare at a significantly elevated baseline risk for both local recurrence and metastasis. [1, 2]
Immunosuppression: Patients with compromised immune systems have a vastly higher incidence and significantly more aggressive cSCC behavior, driving up the likelihood of early locoregional spread. [1, 2]
Prior Interventions: Tumors arising from chronic inflammatory wounds (e.g., burn scars, leg ulcers) and incomplete surgical margins carry a higher probability of early recurrence. [1, 2]

• Redirecting doi.org